ARCHIVES

NCI Bid For New Clinical Review Panel Rejects; But Invites Researchers To ‘Submit Best Ideas’

This article is from The Cancer Letter archive.

Vol. 17 No. 10 | March 8, 1991

Download PDF Visit The Full Archive

Related Articles

“Over-Regulation” Threatens Health Care, Thompson Says.

June 15, 2001

NCI Largely Unaffected By NIH Translational Research Center

February 11, 2011

Amgen, Genzyme, Thoratec Mourn Loss Of Executives Killed In Plane Hijackings.

September 21, 2001

Broder Issues Clinical Alert on 5-FU Levamisle Survival Advantage for Dukes C Colon Cancer

October 6, 1989

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Breast Cancer Low Fat Investigators to Seek R01 Funds for New Compliance, Biochemical Studies

April 25, 1986